3 results
The main objective of this study is to investigate of the drug EMD 525797 is better then no treatment with subjects with metastasized asymptomatic or mild symptomatic mCRPC. The efficacy and safety of the drug EMD 525797 is evaluated.Primary…
To demonstrate the feasibility to induce an effective, predictable and sustained decrease in FGF23 level in CKD stage I-IV patients, without inducing hypophosphatemia using a stepped treatment regimen aiming at restricting phosphate uptake.
The objective of the clinical study is to evaluate the safety and efficacy of the Adagio Cryoablation System (iCLAS*) in the ablation treatment of persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA).